@prefix this: <http://www.tkuhn.ch/bel2nanopub/RAAk3Z6X2ILK60T52M93xYfKDDClC2gjawYFcG7QtqdqU> .
@prefix sub: <http://www.tkuhn.ch/bel2nanopub/RAAk3Z6X2ILK60T52M93xYfKDDClC2gjawYFcG7QtqdqU#> .
@prefix beldoc: <http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix dct: <http://purl.org/dc/terms/> .
@prefix dce: <http://purl.org/dc/elements/1.1/> .
@prefix pav: <http://purl.org/pav/> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix belv: <http://www.selventa.com/vocabulary/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix Protein: <http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_36080> .
@prefix hgnc: <http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=> .
@prefix geneProductOf: <http://purl.obolibrary.org/obo/RO_0002204> .
@prefix sfam: <http://resource.belframework.org/belframework/20131211/namespace/selventa-protein-families/> .
@prefix go: <http://amigo.geneontology.org/amigo/term/GO:> .
@prefix hasAgent: <http://semanticscience.org/resource/SIO_000139> .
@prefix do: <http://disease-ontology.org/term/DOID:> .
@prefix occursIn: <http://purl.obolibrary.org/obo/BFO_0000066> .
@prefix species: <http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=> .
@prefix pubmed: <http://www.ncbi.nlm.nih.gov/pubmed/> .
@prefix orcid: <http://orcid.org/> .

sub:Head {
  this: np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubinfo;
    a np:Nanopublication .
}

sub:assertion {
  sub:_1 geneProductOf: hgnc:19391;
    a Protein: .
  
  sub:_2 geneProductOf: sfam:IFNA%20Family;
    a Protein: .
  
  sub:_3 hasAgent: sub:_4;
    a go:0042789 .
  
  sub:_4 geneProductOf: hgnc:11362;
    a Protein: .
  
  sub:_5 rdf:object sub:_3;
    rdf:predicate belv:increases;
    rdf:subject sub:_2;
    a rdf:Statement .
  
  sub:_6 occursIn: do:715, species:9606;
    rdf:object sub:_5;
    rdf:predicate belv:decreases;
    rdf:subject sub:_1;
    a rdf:Statement .
  
  sub:assertion rdfs:label "p(HGNC:SOCS3) -| (p(SFAM:\"IFNA Family\") -> tscript(p(HGNC:STAT1)))",
      "p(SFAM:\"IFNA Family\") -> tscript(p(HGNC:STAT1))" .
}

sub:provenance {
  beldoc: dce:description "Approximately 61,000 statements.";
    dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved.";
    dce:title "BEL Framework Large Corpus Document";
    pav:authoredBy sub:_8;
    pav:version "20131211" .
  
  sub:_7 prov:value "We have previously shown that in CTCL cells transfected with a dominant negative Stat3, the absence of endogenous SOCS-3 coincides with increased IFNalpha  signaling.19  To provide direct evidence that SOCS-3 does indeed modulate the response to this cytokine, we examined IFNalpha  responses in (i) wt CTCL, (ii) CTCL cells expressing inducible SOCS-3, and (iii) CTCL cells expressing the dominant negative Stat3 (Stat3D), which inhibits the endogenous SOCS-3 expression.19  In agreement with the difference seen previously between SOCS-3hi and SOCS-3lo cells,19  expression of SOCS-3 caused a marked reduction in IFNalpha-induced phosphorylation of both Stat1 and Stat3 (Figure 4a lanes 6 and 8, respectively), whereas induction of the nonactive SOCS-3 mutant had no effect (lanes 10 and 12). Figure 4 legend: SOCS-3 expression inhibits Stat activation induced by IFNalpha  and IL-2, but not IL-4. ";
    prov:wasQuotedFrom pubmed:15618960 .
  
  sub:_8 rdfs:label "Selventa" .
  
  sub:assertion prov:hadPrimarySource pubmed:15618960;
    prov:wasDerivedFrom beldoc:, sub:_7 .
}

sub:pubinfo {
  this: dct:created "2014-07-03T14:32:37.169+02:00"^^xsd:dateTime;
    pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 .
}